Myeong Jin Nam

Myeong Jin Nam


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2010 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
YJYoung Keul Jeon
Young Keul Jeon
YJYun Ho Jang
Yun Ho Jang
DYDong Ryeol Yoo
Dong Ryeol Yoo
SKSi Na Kim
Si Na Kim
SLSang Koo Lee
Sang Koo Lee
MNMyeong Jin Nam
Myeong Jin Nam

1 January 2017 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
HPHyun Jin Park
Hyun Jin Park
YCYong Jun Choi
Yong Jun Choi
JLJeong Hyun Lee
Jeong Hyun Lee
MNMyeong Jin Nam
Myeong Jin Nam

1 October 2011 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
YJYoung Keul Jeon
Young Keul Jeon
DYDong Ryeol Yoo
Dong Ryeol Yoo
YJYun Ho Jang
Yun Ho Jang
SJSe Young Jang
Se Young Jang
MNMyeong Jin Nam
Myeong Jin Nam

16 July 2019 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
YCYong J. Choi
Yong J. Choi
CLChang M. Lee
Chang M. Lee
See-Hyoung ParkSee-Hyoung Park
See-Hyoung Park
MNMyeong Jin Nam
Myeong Jin Nam

1 March 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MNMyeong Jin Nam
Myeong Jin Nam
MKMee K. Kee
Mee K. Kee
RKRork Kuick
Rork Kuick
SHSamir M. Hanash
Samir M. Hanash
There is substantial interest in the identification of circulating human tumor-derived proteins in serum for the purposes of early cancer diagnosis. We have implemented an approach based on the analysis of microarray data for the identification of tumor proteins that may have utility as biomarkers in colon cancer. Expression analysis of microarray data obtained from a variety of 283 tumors and normal tissues revealed that defensin alpha6 was maximally expressed in colon cancer. These findings were corroborated by reverse transcription-PCR, in which the colon cancer cell lines LoVo, Caco2, HCT-15, SW480, and SW620 showed significantly higher levels of defensin alpha6 expression than did non-colon cancer cell lines. Moreover, our data were concordant with data obtained from the NCI, National Institutes of Health Cancer Genome Anatomy Project. To evaluate defensin alpha6 as a potential biomarker of colon cancer, a preliminary "training" set of serum from 91 healthy donors and 109 colon cancer patients was analyzed by enzyme-linked immunosorbent assay. The data pattern was confirmed by an independent set of 67 masked serum samples: 18 from healthy donors and 49 from colon cancer patients. This result yielded a sensitivity of 69.4% (95% CI 54.6-81.8), specificity of 83.3% (58.6-96.4), and positive predictive value of 91.9% (78.1-98.3). These findings justify a prospective assessment of serum defensin alpha6 protein as a screening tool for colon cancer.

Verified
Journal Article
Open access
PDF file
CLChang Min Lee
Chang Min Lee
Jongsung LeeJongsung Lee
Jongsung Lee
MNMyeong Jin Nam
Myeong Jin Nam
YCYoun Soo Choi
Youn Soo Choi
See-Hyoung ParkSee-Hyoung Park
See-Hyoung Park
Tomentosin is a natural sesquiterpene lactone extracted from various plants and is widely used as a medicine because it exhibits essential therapeutic properties. In this study, we investigated the anti-carcinogenic effects of tomentosin in human osteosarcoma MG-63 cells by performing cell migration/viability/proliferation, apoptosis, and reactive oxygen species (ROS) analysis assays. MG-63 cells were treated with various doses of tomentosin. After treatment with tomentosin, MG-63 cells were analyzed using the MTT assay, colony formation assay, cell counting assay, wound healing assay, Boyden chamber assay, zymography assay, cell cycle analysis, FITC Annexin V apoptosis assay, terminal deoxynucleotidyl transferase dUTP nick end labeling assay, western blot analysis, and ROS detection analysis. Our results indicated that tomentosin decreased cell viability and migration ability in MG-63 cells. Moreover, tomentosin induced apoptosis, cell cycle arrest, DNA damage, and ROS production in MG-63 cells. Furthermore, tomentosin-induced intracellular ROS decreased cell viability and induced apoptosis, cell cycle arrest, and DNA damage in MG-63 cells. Taken together, our results suggested that tomentosin exerted anti-carcinogenic effects in MG-63 cells by induction of intracellular ROS.